Number of the records: 1
14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains
- 1.
SYSNO ASEP 0544647 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains Author(s) Pohl, Pavel (FGU-C) ORCID
Joshi, Rohit (FGU-C)
Petrvalská, Olivia (FGU-C) RID, ORCID, SAI
Obšil, Tomáš (FGU-C) RID, ORCID
Obšilová, Veronika (FGU-C) RID, ORCID, SAIArticle number 899 Source Title Communications Biology. - : Nature Publishing Group
Roč. 4, č. 1 (2021)Number of pages 15 s. Language eng - English Country GB - United Kingdom Keywords protein structure and function ; ubiquitination ; 14-3-3 protein ; Nedd4-2 ubiquitin ligase ; phosphorylation Subject RIV CE - Biochemistry OECD category Biochemistry and molecular biology R&D Projects GA20-00058S GA ČR - Czech Science Foundation (CSF) Research Infrastructure CIISB - 90043 - Masarykova univerzita Method of publishing Open access Institutional support FGU-C - RVO:67985823 UT WOS 000680395000002 EID SCOPUS 85111089437 DOI 10.1038/s42003-021-02419-0 Annotation Neural precursor cell expressed developmentally down-regulated 4 ligase (Nedd4-2) is an E3 ubiquitin ligase that targets proteins for ubiquitination and endocytosis, thereby regulating numerous ion channels, membrane receptors and tumor suppressors. Nedd4-2 activity is regulated by autoinhibition, calcium binding, oxidative stress, substrate binding, phosphorylation and 14-3-3 protein binding. However, the structural basis of 14-3-3-mediated Nedd4-2 regulation remains poorly understood. Here, we combined several techniques of integrative structural biology to characterize Nedd4-2 and its complex with 14-3-3. We demonstrate that phosphorylated Ser342 and Ser448 are the key residues that facilitate 14-3-3 protein binding to Nedd4-2 and that 14-3-3 protein binding induces a structural rearrangement of Nedd4-2 by inhibiting interactions between its structured domains. Overall, our findings provide the structural glimpse into the 14-3-3-mediated Nedd4-2 regulation and highlight the potential of the Nedd4-2:14-3-3 complex as a pharmacological target for Nedd4-2-associated diseases such as hypertension, epilepsy, kidney disease and cancer. Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2022 Electronic address https://doi.org/10.1038/s42003-021-02419-0
Number of the records: 1